David Adler

Operation Precision Aliyah

While the following story is fictional, the strategic question is serious.

At 2:07 a.m., the Mossad Director was summoned to the Prime Minister’s Office.

He arrived expecting Iran, an arms shipment or a terrorist cell.

Instead, the Prime Minister pushed a red folder across the desk.

“I have a new operation for you.”

The director opened it.

A pharmaceutical-development executive in Basel.

A deep-tech CEO in Boston.

A senior Core AI specialist in Toronto.

An Israeli technology executive who had spent twenty years in Palo Alto.

The director looked up.

“What have they done?”

“Nothing.”

“Then why are you showing me their photographs?”

“I asked the government’s economic and innovation teams which capabilities Israel needs more of but cannot build quickly at home.”

“And?”

“They gave me the gaps.”

The Prime Minister tapped the folder.

“I asked for names.”

The director looked at the photographs again.

“What do you want the Mossad to do?”

“Persuade them to move to Israel.”

“You called me at two in the morning to recruit executives?”

“I called you to bring strategic capabilities to Israel.”

“That sounds remarkably similar.”

“I’m calling it Operation Precision Aliyah.”

The director frowned.

“Aliyah already exists.”

“Of course. Nothing changes. Anyone eligible under the Law of Return can make aliyah, regardless of profession, education or résumé.”

“Then what is precision about it?”

“The operation. For someone already eligible, aliyah is the existing legal pathway if we persuade that person to move to Israel. Your targets have already been identified. Your job is persuasion.”

The director nodded toward the Palo Alto photograph.

“And him?”

“Already Israeli.”

“So less paperwork.”

“Consider it the easy file.”

The director looked at the four photographs.

“You may be underestimating the paperwork.”

And so began Operation Precision Aliyah.

FILE: BASEL

The first target had spent twenty-five years inside global pharmaceutical R&D.

An operative approached him after a conference in Basel.

“I’d like to talk to you about moving to Israel.”

“That is unusually direct.”

“We have a limited budget for coffee.”

The executive smiled.

“Why me?”

“Because Israel has outstanding biomedical scientists, hospitals and biotech startups. What it has fewer of are people who have spent decades doing what happens after promising science becomes a development program.”

“Meaning?”

“You have led global clinical development. You have worked through regulatory strategy, trial design, development decisions and the inevitable moment when a drug candidate does not perform as predicted.”

“That happens occasionally.”

“We have been informed.”

“You have excellent scientists in Israel.”

“Exactly. We are not trying to import better science. We are trying to add more people who know how to turn promising science into medicines.”

The executive leaned back.

“And what exactly would I do?”

The operative paused.

“You would bring that experience to Israel.”

“That explains why Israel needs me.”

“Yes.”

“It does not explain why I need Israel.”

A longer pause.

The operative called headquarters.

“We have identified the problem.”

“What problem?”

“We have a strategic need.”

“And?”

“We do not yet have a professional proposition.”

Basel produced the first lesson of Operation Precision Aliyah.

Knowing why Israel wants somebody is not the same as giving that person a reason to come.

FILE: BOSTON

By Boston, the Mossad had updated the briefing.

This target had taken a deep-tech company built around difficult technology from an early technical organization into a global business.

He had recruited a management team, raised growth capital, built manufacturing capability and taken the company into international markets.

This time the operative arrived with something more concrete.

“We have a proposition.”

“I receive propositions every week.”

“This one requires moving countries.”

“That eliminates several.”

“There is an Israeli deep-tech company with strong technology, an engineering organization, early international customers and a problem.”

“What problem?”

“It has reached the point where excellent technology is no longer enough.”

The executive smiled.

“A familiar problem.”

“It now needs someone who has already built the management team, raised serious growth capital, scaled manufacturing and opened global markets.”

“And you think that person is me?”

“You have already done all four.”

Now he was listening.

“What would I control?”

“The company.”

“Authority?”

“Yes.”

“Resources?”

“Yes.”

“Compensation?”

“Competitive.”

“With Boston?”

The operative called headquarters.

“How competitive are we?”

“Competitive.”

“With Boston.”

Silence.

“I’ll call the board.”

The operative covered the phone.

“We have reached a more difficult phase of the operation.”

The Mossad had discovered the central rule of Precision Aliyah:

Eligibility for aliyah is not a job offer.

If Israel wants exceptional people, it has to compete for them.

Not by asking them to sacrifice their careers.

By offering them the chance to do something larger with those careers.

Build an organization.

Create a capability.

Take responsibility they might never receive inside a much larger institution.

And if contributing to Israel also carries personal meaning, that can make a strong professional opportunity even stronger.

But the professional opportunity has to come first.

Neither sentiment nor, as the Mossad would soon discover, halva can repair a bad offer.

FILE: PALO ALTO

This target was already Israeli.

He had left twenty years earlier and built a successful career scaling technology companies globally.

The operative met him for coffee.

“Do you ever think about coming home?”

“Sometimes.”

“Do you miss Israel?”

“Yes.”

“The Mediterranean?”

“Yes.”

“Friday afternoon when everything starts slowing down?”

“Yes.”

“Shabbat dinner with cousins, cousins of cousins and neighbors who somehow become family by dessert?”

The executive laughed.

“Very much.”

The operative sensed movement.

“Hummus?”

“Yes.”

“Halva?”

“What kind?”

Headquarters was notified.

POSITIVE SIGNAL DETECTED.

A package was dispatched from Tel Aviv.

For administrative purposes, it was classified:

TACTICAL CONFECTIONERY, SESAME-BASED.

Two days later, the executive called.

“The halva was excellent.”

“So you’re coming?”

“No.”

Another setback.

“Why not?”

“My career is here. My wife’s career is here. My children are in school. My professional network is here.”

The operative called headquarters.

“He misses Israel.”

“Excellent.”

“He still doesn’t want to move.”

“Less excellent.”

“What does he want?”

“A role as global as the one he already has.”

A pause.

“Then build one.”

That was another lesson.

Nostalgia could reopen a door.

It could not make the decision.

If Israel wanted experienced Israelis back, the opportunity had to compete with the lives they had built abroad.

That meant serious roles, international scope, help for spouses with careers, schools for children and enough flexibility to remain connected to global markets.

The halva could stay.

But it was no longer the strategy.

FILE: TORONTO

The Toronto target was a senior specialist in Core AI.

At the first meeting, he appeared genuinely puzzled.

“Israel needs AI people?”

“Israel is exceptionally strong in AI.”

“Then why are you here?”

“Strong does not mean fully supplied. There are specialized Core AI roles where experienced talent remains scarce.”

“That sounds surprisingly reasonable.”

“We have been improving.”

This time the Mossad arrived prepared.

The role was defined.

The resources were real.

The professional opportunity was credible.

The target listened carefully.

Then he said:

“No.”

A second meeting produced the same result.

Professional opportunity?

Still no.

National contribution?

No.

Family connections?

No.

Finally, someone tried weather.

This argument was considered especially strong in February.

Still no.

Headquarters held an operational review.

“What are we missing?”

An analyst raised his hand.

“Perhaps he simply does not want to move.”

Silence.

The possibility had received insufficient attention.

Finally someone asked:

“Do we actually need him to move?”

Could he advise an Israeli AI program?

Yes.

Join the board of an Israeli company?

Yes.

Spend several weeks each year working with Israeli teams?

Possibly.

Connect Israeli companies to expertise and networks abroad?

Absolutely.

A new classification was created:

TARGET NOT ACQUIRED. CAPABILITY PARTIALLY ACQUIRED.

The wording was inelegant.

The strategy was not.

By then, Operation Precision Aliyah had evolved.

Some people would make aliyah.

Some Israelis abroad might return.

Others would never relocate but could still bring knowledge, networks and experience closer to Israel.

The common starting point was capability.

Where does Israel have excellent science but need more accumulated experience turning it into medicines?

Where does strong deep technology need more executives who have already taken companies through scale-up and global commercialization?

Where are highly specialized skills genuinely scarce?

Where has an Israeli abroad accumulated twenty years of experience that would take another twenty years to reproduce?

Then find the people who already possess it.

And if Israel wants them, offer them something worth coming for.

Because twenty or thirty years of accumulated experience is not simply another line on a résumé.

Sometimes it is infrastructure.

Months later, the Mossad Director returned to the Prime Minister’s Office.

This time it was 10:30 in the morning.

There was coffee.

There was also halva.

He placed the first operational report on the desk.

OPERATION PRECISION ALIYAH

Basel: Pharmaceutical-development executive. Concrete mandate developed. Negotiations progressing.

Boston: Deep-tech CEO. Relocating. Compensation package eventually approved.

Toronto: Core AI specialist. Declined relocation. Accepted advisory role.

Palo Alto: Israeli technology executive. Second meeting scheduled. Halva supplies adequate.

The Prime Minister studied the report.

Then he looked up.

“How many people did we bring?”

The Mossad Director shook his head.

“Wrong question.”

He closed the folder.

“Ask me what capabilities we brought.”

About the Author
Professor David Adler is Chief Scientific & Medical Officer of the PATHORA Institute of Pathology & Tissue Medicine. He is a senior pharmaceutical leader in oncology drug development and translational medicine with over 15 years of experience, including a decade in senior leadership at Bayer AG’s Global Oncology Clinical Development organization. He holds academic appointments at the Hebrew University of Jerusalem, Ben-Gurion University of the Negev, and the University of Bonn.
Related Topics
Related Posts
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.